PBLS Parabilis Medicines, Inc.
Price Chart
Executive Summary
Richard Klausner filed a Form 3 initial statement of beneficial ownership with Parabilis Medicines, Inc. (PBLS), disclosing stock option holdings of 21,273 shares exercisable at $4.62 and 48,736 shares exercisable at $1.88. This is a routine filing required upon becoming an insider, with no trading activity or material financial impact.
Actionable Insight
This is a routine insider onboarding filing with no trading signal. Monitor future Form 4 filings for any open-market purchases or sales by Klausner, which would provide actionable information.
Key Facts
- Richard Klausner filed a Form 3 initial beneficial ownership statement on June 9, 2026.
- Klausner holds stock options to buy 21,273 shares at $4.62 (fully vested) and 48,736 shares at $1.88 (vesting schedule: 25% on Dec 11, 2025, remainder monthly over 36 months).
- No actual share purchases or sales are reported; only derivative holdings.
- The filing is administrative, required under Section 16(a) for new insiders.
Financial Impact
No financial impact; filing discloses existing option holdings only.
Risk Factors
- No material risks identified from this filing.
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-264578 |
| Document: 0001193125-26-264578-index-headers.html | 0001193125-26-264578 |
| Document: 0001193125-26-264578-index.html | 0001193125-26-264578 |
| Document: 0001193125-26-264578.txt | 0001193125-26-264578 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
3d ago
|
8-K
| $30.30 awaiting T+20 | awaiting T+20 | — | $27.26 (−10.03%) |
|
Jun 10, 2026
4d ago
|
424B4
| $32.16 awaiting T+20 | awaiting T+20 | — | $27.26 (−15.24%) |
|
Jun 10, 2026
5d ago
|
EFFECT
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
3
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
3
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
3
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
3
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
3
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
3
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
Press Release
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access